Last updated on August 2018

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States


Find a site near you

Start Over

Willis Knighton Cancer Center

Shreveport, LA United States
2.49miles
  Connect »